Importer of Controlled Substances Application: Cerilliant Corporation, 56631-56633 [2020-20159]
Download as PDF
56631
Federal Register / Vol. 85, No. 178 / Monday, September 14, 2020 / Notices
agreements. All non-confidential
written submissions will be available for
public inspection at the Office of the
Secretary and on EDIS.
The Commission vote for these
determinations took place on September
8, 2020.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: September 8, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020–20122 Filed 9–11–20; 8:45 am]
BILLING CODE 7020–02–P
Drug Enforcement Administration
[Docket No. DEA–713]
Importer of Controlled Substances
Application: Cerilliant Corporation
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Cerilliant Corporation has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 14, 2020. Such
persons may also file a written request
for a hearing on the application on or
before October 14, 2020.
SUMMARY:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
DEPARTMENT OF JUSTICE
In
accordance with 21 CFR 1301.34(a), this
is notice that on July 23, 2020, Cerilliant
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78665–2402,
applied to be registered as an importer
of the following basic classes of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Drug code
3-Fluoro-N-methylcathinone (3-FMC) ....................................................................................................................................
Cathinone ..............................................................................................................................................................................
Methcathinone .......................................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) ....................................................................................................................................
Pentedrone (a-methylaminovalerophenone) .........................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ..........................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) ......................................................................................................................................
Naphyrone .............................................................................................................................................................................
N-Ethylamphetamine .............................................................................................................................................................
N,N-Dimethylamphetamine ....................................................................................................................................................
Fenethylline ...........................................................................................................................................................................
Methaqualone ........................................................................................................................................................................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .........................................................................................................
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) .......................................................
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl] (2,2,3,3-tetramethylcyclopropyl)methanone .....................
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) .............................................................................................................................
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................................
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) .......................................................................
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ......................
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ........................................
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ..................................................................
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .........................................................................................................
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ...........................................................................
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ....................................................................................
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ............................................................................................................
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ........................................................................
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ..............................................................................................................................
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .................................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) .............................................................................................................
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ............................................................................................................
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ........................................................................................................
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ....................................................................................
Alpha-ethyltryptamine ............................................................................................................................................................
Ibogaine .................................................................................................................................................................................
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .......................................................................
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .................................................
Lysergic acid diethylamide ....................................................................................................................................................
2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine .......................................................................................................
Marihuana ..............................................................................................................................................................................
Parahexyl ...............................................................................................................................................................................
Mescaline ...............................................................................................................................................................................
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) ..................................................................................................
3,4,5-Trimethoxyamphetamine ..............................................................................................................................................
VerDate Sep<11>2014
17:51 Sep 11, 2020
Jkt 250001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
E:\FR\FM\14SEN1.SGM
14SEN1
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
2565
6250
7008
7011
7012
7019
7023
7024
7031
7035
7048
7081
7104
7118
7122
7144
7173
7200
7201
7203
7222
7225
7249
7260
7297
7298
7315
7348
7360
7374
7381
7385
7390
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
56632
Federal Register / Vol. 85, No. 178 / Monday, September 14, 2020 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Drug code
4-Bromo-2,5-dimethoxyamphetamine ...................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine ...................................................................................................................................
2,5-Dimethoxyamphetamine ..................................................................................................................................................
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ............................................................................................................
3,4-Methylenedioxyamphetamine ..........................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ........................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ........................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .............................................................................................................................
3,4-Methylenedioxymethamphetamine ..................................................................................................................................
4-Methoxyamphetamine ........................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .......................................................................................................................................
Alpha-methyltryptamine .........................................................................................................................................................
Bufotenine ..............................................................................................................................................................................
Diethyltryptamine ...................................................................................................................................................................
Dimethyltryptamine ................................................................................................................................................................
Psilocybin ...............................................................................................................................................................................
Psilocyn .................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ...................................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ..........................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ..........................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .....................................................................................................................................
N-Benzylpiperazine ................................................................................................................................................................
4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ...........................................................................................................
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) ........................................................................................................
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ............................................................................................................
2C-H 2-(2,5-Dimethoxyphenyl) ethanamine) .........................................................................................................................
2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ................................................................................................................
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ..........................................................................................................
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ...........................................................................................................
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ....................................................................................................
2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ...........................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .............................................................................................................................
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ...........................................................
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ...........................................................
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ............................................................................................................
Butylone .................................................................................................................................................................................
Pentylone ...............................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ..............................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ................................................................................................................................
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ..........................................................................................................
Desomorphine .......................................................................................................................................................................
Etorphine (except HCl) ..........................................................................................................................................................
Codeine methylbromide .........................................................................................................................................................
Heroin ....................................................................................................................................................................................
Morphine-N-oxide ..................................................................................................................................................................
Normorphine ..........................................................................................................................................................................
Pholcodine .............................................................................................................................................................................
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .....................................................................
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ........................................................................
Acetylmethadol ......................................................................................................................................................................
Allylprodine ............................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ............................................................................................................
Alphameprodine .....................................................................................................................................................................
Alphamethadol .......................................................................................................................................................................
Betacetylmethadol .................................................................................................................................................................
Betameprodine ......................................................................................................................................................................
Betamethadol .........................................................................................................................................................................
Betaprodine ...........................................................................................................................................................................
Dextromoramide ....................................................................................................................................................................
Dipipanone .............................................................................................................................................................................
Hydroxypethidine ...................................................................................................................................................................
Noracymethadol .....................................................................................................................................................................
Norlevorphanol ......................................................................................................................................................................
Normethadone .......................................................................................................................................................................
Racemoramide ......................................................................................................................................................................
Trimeperidine .........................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ............................................................................................................................
Tilidine ...................................................................................................................................................................................
Para-Fluorofentanyl ...............................................................................................................................................................
3-Methylfentanyl ....................................................................................................................................................................
Alpha-methylfentanyl .............................................................................................................................................................
Acetyl-alpha-methylfentanyl ...................................................................................................................................................
VerDate Sep<11>2014
17:51 Sep 11, 2020
Jkt 250001
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
E:\FR\FM\14SEN1.SGM
14SEN1
7391
7392
7395
7396
7398
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7455
7458
7470
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7545
7546
7694
9055
9056
9070
9200
9307
9313
9314
9547
9551
9601
9602
9603
9604
9605
9607
9608
9609
9611
9613
9622
9627
9633
9634
9635
9645
9646
9661
9750
9812
9813
9814
9815
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
56633
Federal Register / Vol. 85, No. 178 / Monday, September 14, 2020 / Notices
Controlled substance
Drug code
Beta-hydroxyfentanyl .............................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ..............................................................................................................................................
Alpha-methylthiofentanyl .......................................................................................................................................................
3-Methylthiofentanyl ...............................................................................................................................................................
Thiofentanyl ...........................................................................................................................................................................
Fentanyl related-substances as defined in 21 CFR 1308.11(h) ...........................................................................................
Methamphetamine .................................................................................................................................................................
Methylphenidate ....................................................................................................................................................................
Amobarbital ............................................................................................................................................................................
Pentobarbital ..........................................................................................................................................................................
Secobarbital ...........................................................................................................................................................................
Glutethimide ...........................................................................................................................................................................
Nabilone .................................................................................................................................................................................
1-Phenylcyclohexylamine ......................................................................................................................................................
Phencyclidine .........................................................................................................................................................................
Phenylacetone .......................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ......................................................................................................................................
Alphaprodine ..........................................................................................................................................................................
Dihydrocodeine ......................................................................................................................................................................
Ecgonine ................................................................................................................................................................................
Ethylmorphine ........................................................................................................................................................................
Levomethorphan ....................................................................................................................................................................
Levorphanol ...........................................................................................................................................................................
Meperidine .............................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ....................................................................................................................
Levo-alphacetylmethadol .......................................................................................................................................................
Noroxymorphone ...................................................................................................................................................................
Racemethorphan ...................................................................................................................................................................
Alfentanil ................................................................................................................................................................................
Remifentanil ...........................................................................................................................................................................
Sufentanil ...............................................................................................................................................................................
Carfentanil .............................................................................................................................................................................
Tapentadol .............................................................................................................................................................................
The company plans to import the
listed controlled substances for the
manufacturing of analytical reference
standards and distribution to their
research and forensic customers.
Approval of permit application will
occur only when the registrant’s activity
is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization
will not extend to the import of Food
and Drug Administration-approved or
non-approved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–20159 Filed 9–11–20; 8:45 am]
BILLING CODE P
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 13, 2020 Such
persons may also file a written request
for a hearing on the application on or
before November 13, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
In
accordance with 21 CFR 1301.33(a), this
is notice that on August 5, 2020,
Organix Inc., 240 Salem Street, Woburn,
Massachusetts 01801–2029, applied to
be registered as a bulk manufacturer of
the following basic class(es) of a
controlled substance(s):
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
khammond on DSKJM1Z7X2PROD with NOTICES
[Docket No. DEA–712]
Bulk Manufacturer of Controlled
Substances Application: Organix Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Organix Inc. has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
Controlled substance
Drug code
5-Methoxy-N-Ndimethyltryptamine.
7431
Schedule
I
SUMMARY:
VerDate Sep<11>2014
17:51 Sep 11, 2020
Jkt 250001
The company plans to synthesize the
above-listed controlled substance for
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
9830
9831
9832
9833
9835
9850
1105
1724
2125
2270
2315
2550
7379
7460
7471
8501
8603
9010
9120
9180
9190
9210
9220
9230
9273
9648
9668
9732
9737
9739
9740
9743
9780
Schedule
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
distribution to its customers. No other
activity for this drug code is authorized
for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–20162 Filed 9–11–20; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–709]
Bulk Manufacturer of Controlled
Substances Application: Cambridge
Isotype Lab
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Cambridge Isotype Lab has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug(s) information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 13, 2020. Such
SUMMARY:
E:\FR\FM\14SEN1.SGM
14SEN1
Agencies
[Federal Register Volume 85, Number 178 (Monday, September 14, 2020)]
[Notices]
[Pages 56631-56633]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20159]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-713]
Importer of Controlled Substances Application: Cerilliant
Corporation
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cerilliant Corporation has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before October 14,
2020. Such persons may also file a written request for a hearing on the
application on or before October 14, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on July 23, 2020, Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas 78665-2402, applied to be registered
as an importer of the following basic classes of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)......... 1233 I
Cathinone.................................. 1235 I
Methcathinone.............................. 1237 I
4-Fluoro-N-methylcathinone (4-FMC)......... 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N-methylcathinone).... 1248 I
4-Methyl-N-ethylcathinone (4-MEC).......... 1249 I
Naphyrone.................................. 1258 I
N-Ethylamphetamine......................... 1475 I
N,N-Dimethylamphetamine.................... 1480 I
Fenethylline............................... 1503 I
Methaqualone............................... 2565 I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) 6250 I
indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-methoxyphenylacetyl)
indole).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl] (2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan- 7012 I
2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
carboxamide).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).... 7019 I
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7023 I
yl)-1-pentyl-1H-indazole-3-carboxamide).
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3- 7024 I
yl](naphthalen-1-yl)methanone).
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan- 7031 I
2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide).
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl- 7048 I
1H-indazole-3-carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) 7081 I
indole).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4- 7104 I
methoxy)-benzoyl] indole).
JWH-018 (also known as AM678) (1-Pentyl-3- 7118 I
(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) 7122 I
indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-naphthoyl)indole).... 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) 7201 I
indole).
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) 7203 I
indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- 7222 I
carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)- 7225 I
1H-indole-3-carboxylate).
Alpha-ethyltryptamine...................... 7249 I
Ibogaine................................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide................. 7315 I
2C-T-7 (2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine.
Marihuana.................................. 7360 I
Parahexyl.................................. 7374 I
Mescaline.................................. 7381 I
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine ).
3,4,5-Trimethoxyamphetamine................ 7390 I
[[Page 56632]]
4-Bromo-2,5-dimethoxyamphetamine........... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine........ 7392 I
4-Methyl-2,5-dimethoxyamphetamine.......... 7395 I
2,5-Dimethoxyamphetamine................... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) 7398 I
indole).
3,4-Methylenedioxyamphetamine.............. 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine.... 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine.... 7402 I
3,4-Methylenedioxy-N-ethylamphetamine...... 7404 I
3,4-Methylenedioxymethamphetamine.......... 7405 I
4-Methoxyamphetamine....................... 7411 I
5-Methoxy-N-N-dimethyltryptamine........... 7431 I
Alpha-methyltryptamine..................... 7432 I
Bufotenine................................. 7433 I
Diethyltryptamine.......................... 7434 I
Dimethyltryptamine......................... 7435 I
Psilocybin................................. 7437 I
Psilocyn................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine........ 7439 I
N-Ethyl-1-phenylcyclohexylamine............ 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine.......... 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine...... 7470 I
N-Benzylpiperazine......................... 7493 I
4-MePPP (4-Methyl- 7498 I
alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine).
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine).
2C-H 2-(2,5-Dimethoxyphenyl) ethanamine)... 7517 I
2C-I 2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine).
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone)...... 7535 I
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)- 7536 I
N-(2-methoxybenzyl) ethanamine).
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)- 7537 I
N-(2-methoxybenzyl) ethanamine).
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N- 7538 I
(2-methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone................................... 7541 I
Pentylone.................................. 7542 I
alpha-pyrrolidinopentiophenone ([alpha]- 7545 I
PVP).
alpha-pyrrolidinobutiophenone ([alpha]-PBP) 7546 I
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
Desomorphine............................... 9055 I
Etorphine (except HCl)..................... 9056 I
Codeine methylbromide...................... 9070 I
Heroin..................................... 9200 I
Morphine-N-oxide........................... 9307 I
Normorphine................................ 9313 I
Pholcodine................................. 9314 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]benzamide)).
Acetylmethadol............................. 9601 I
Allylprodine............................... 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine............................. 9604 I
Alphamethadol.............................. 9605 I
Betacetylmethadol.......................... 9607 I
Betameprodine.............................. 9608 I
Betamethadol............................... 9609 I
Betaprodine................................ 9611 I
Dextromoramide............................. 9613 I
Dipipanone................................. 9622 I
Hydroxypethidine........................... 9627 I
Noracymethadol............................. 9633 I
Norlevorphanol............................. 9634 I
Normethadone............................... 9635 I
Racemoramide............................... 9645 I
Trimeperidine.............................. 9646 I
1-Methyl-4-phenyl-4-propionoxypiperidine... 9661 I
Tilidine................................... 9750 I
Para-Fluorofentanyl........................ 9812 I
3-Methylfentanyl........................... 9813 I
Alpha-methylfentanyl....................... 9814 I
Acetyl-alpha-methylfentanyl................ 9815 I
[[Page 56633]]
Beta-hydroxyfentanyl....................... 9830 I
Beta-hydroxy-3-methylfentanyl.............. 9831 I
Alpha-methylthiofentanyl................... 9832 I
3-Methylthiofentanyl....................... 9833 I
Thiofentanyl............................... 9835 I
Fentanyl related-substances as defined in 9850 I
21 CFR 1308.11(h).
Methamphetamine............................ 1105 II
Methylphenidate............................ 1724 II
Amobarbital................................ 2125 II
Pentobarbital.............................. 2270 II
Secobarbital............................... 2315 II
Glutethimide............................... 2550 II
Nabilone................................... 7379 II
1-Phenylcyclohexylamine.................... 7460 II
Phencyclidine.............................. 7471 II
Phenylacetone.............................. 8501 II
1-Piperidinocyclohexanecarbonitrile........ 8603 II
Alphaprodine............................... 9010 II
Dihydrocodeine............................. 9120 II
Ecgonine................................... 9180 II
Ethylmorphine.............................. 9190 II
Levomethorphan............................. 9210 II
Levorphanol................................ 9220 II
Meperidine................................. 9230 II
Dextropropoxyphene, bulk (non-dosage forms) 9273 II
Levo-alphacetylmethadol.................... 9648 II
Noroxymorphone............................. 9668 II
Racemethorphan............................. 9732 II
Alfentanil................................. 9737 II
Remifentanil............................... 9739 II
Sufentanil................................. 9740 II
Carfentanil................................ 9743 II
Tapentadol................................. 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
the manufacturing of analytical reference standards and distribution to
their research and forensic customers. Approval of permit application
will occur only when the registrant's activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend
to the import of Food and Drug Administration-approved or non-approved
finished dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-20159 Filed 9-11-20; 8:45 am]
BILLING CODE P